Filecoin vs Enzyme — how do they compare? Filecoin trades at Rp11,923 (market cap Rp9,74T, Rp576,77M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Filecoin is far larger — about 72616.1× Enzyme's market cap, and Filecoin's circulating supply is 819,2M FIL versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Filecoin for 97 Days and Enzyme for 29 Days on average.
| FIL | MLN | |
|---|---|---|
Market Cap | Rp9,74T | Rp134,13M |
Volume (24h) | Rp576,77M | Rp104,56M |
Circulating Supply | 819,2M FIL | 3,3M MLN |
Typical Hold Time | 97 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Filecoin is currently trading at Rp11,923 with a market cap of Rp9.74T, showing bearish technical signals across moving averages and oscillators. The asset faces strong resistance at Rp12,010 (pivot point) with support at Rp11,849. RSI levels around 31-32 indicate neutral momentum while ADX readings above 50 confirm a strong downtrend. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential bounce from oversold conditions near support levels. Major risks include continued selling pressure, low trading volumes, and crypto market volatility. Investors should monitor for any network upgrades or ecosystem developments that could shift momentum.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
FIL is a cryptocurrency that powers Filecoin, a decentralized storage network that aims to let anyone store, retrieve, and host digital information. Its decentralized nature protects the integrity of a data's location, making it easily retrievable and hard to censor.
Read more on FIL →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →